A copper-based compound has cut Alzheimer’s toxic protein accumulation by 42 percent in laboratory cell models, opening a potential new avenue for treating the disease.
A copper-based compound has cut Alzheimer’s toxic protein accumulation by 42 percent in laboratory cell models, opening a potential new avenue for treating the disease.